Results 81 to 90 of about 14,976,458 (288)

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Federated learning with continual update for privacy-preserving clinical event prediction across distributed hospitals using MCN-GNN

Scientific Reports
Federated Learning (FL) enables accurate and secure Clinical Event Prediction (CEP) across distributed hospitals. However, the prevailing works overlooked the catastrophic forgetting during the global update. Therefore, a Meta Experience Polynomial Decay-
K. Jagdeesh, N. Kanimozhi, Tanvir H. Sardar, N. Naveenkumar, B. Mahalakshmi, A. Chandrasekar, M. Karpagam, Sk Mahmudul Hasan   +7 more
doaj   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

ISAAC: Prior-aligned structural sensitivity auditing for drug–target interaction models

Artificial Intelligence in the Life Sciences
Deep learning models for drug–target interaction (DTI) prediction often achieve strong benchmark performance while relying on input patterns that are not captured by standard accuracy-based evaluation.
Barbara Tarantino, Sun Kim, Yijingxiu Lu, Paolo Giudici   +3 more
doaj   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

Molecular Oncology, EarlyView.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho, Chenqian Liu, W. Lee Kraus   +2 more
wiley   +1 more source

A Novel Sequential Monte Carlo Algorithm for Parameter Estimation in Eco‐Hydrological Models

Water Resources Research
Bayesian inference offers a flexible framework for parameter estimation and uncertainty quantification in eco‐hydrological models. However, simultaneously achieving robust posterior exploration and high computational efficiency for multimodal, high ...
Cong Xu, Kun Zhang, Gaofeng Zhu, Xin Li, Chuang Wei   +4 more
doaj   +1 more source

Assessing Stand-to-Sit Kinematics via mmWave Radar: A Real-to-Sim Robust Bidirectional State-Space Model

Applied Sciences
Continuous monitoring of the Stand-to-Sit (STS) transition serves as a critical indicator of lower-limb frailty in the elderly, for which millimeter-wave radar provides an ideal privacy-preserving, device-free sensing solution.
Yancheng Liu, Yan Fu, Le Chang, Zhengke Gao, Alex Mihailidis   +4 more
doaj   +1 more source